BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38732068)

  • 1. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.
    Valdez CN; Sánchez-Zuno GA; Bucala R; Tran TT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation.
    Jia X; Xi J; Tian B; Zhang Y; Wang Z; Wang F; Li Z; Long J; Wang J; Fan GH; Li Q
    Cancer Immunol Res; 2024 Jan; 12(1):72-90. PubMed ID: 37956411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas.
    Liu W; Yang HS; Zhi FH; Feng YF; Luo HH; Zhu Y; Lei YY
    Clin Transl Med; 2023 Oct; 13(10):e1368. PubMed ID: 37784249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma.
    Wu L; Gao Y; Xie S; Ye W; Uemura Y; Zhang R; Yu Y; Li J; Chen M; Wu Q; Cui P; Liu H; Mu S; Li Y; Wang L; Liu C; Li J; Zhang L; Jiao S; Zhang G; Liu T
    Transl Oncol; 2023 Nov; 37():101775. PubMed ID: 37678132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic stem cells secrete macrophage migration inhibitory factor: A novel finding.
    Wei Y; Zheng X; Huang T; Zhong Y; Sun S; Wei X; Liu Q; Wang T; Zhao Z
    PLoS One; 2023; 18(8):e0288281. PubMed ID: 37616250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.
    Carr SR; Wang H; Hudlikar R; Lu X; Zhang MR; Hoang CD; Yan F; Schrump DS
    J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1554-1564. PubMed ID: 37608989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma.
    Bian Y; Bi G; Shan G; Liang J; Yao G; Sui Q; Hu Z; Zhan C; Chen Z; Wang Q
    Heliyon; 2023 Aug; 9(8):e18132. PubMed ID: 37529341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer.
    Huth S; Huth L; Heise R; Marquardt Y; Lopopolo L; Piecychna M; Boor P; Fingerle-Rowson G; Kapurniotu A; Yazdi AS; Bucala R; Bernhagen J; Baron JM
    Sci Rep; 2023 Jul; 13(1):11611. PubMed ID: 37464010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism.
    Yada RC; Desa DE; Gillette AA; Bartels E; Harari PM; Skala MC; Beebe DJ; Kerr SC
    Biomaterials; 2023 Jul; 298():122136. PubMed ID: 37178589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36
    Zhu GQ; Tang Z; Huang R; Qu WF; Fang Y; Yang R; Tao CY; Gao J; Wu XL; Sun HX; Zhou YF; Song SS; Ding ZB; Dai Z; Zhou J; Ye D; Wu DJ; Liu WR; Fan J; Shi YH
    Cell Discov; 2023 Mar; 9(1):25. PubMed ID: 36878933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK4 silencing in gastric cancer drives liver metastasis by positive feedback between cancer cells and macrophages.
    Li S; Guo D; Sun Q; Zhang L; Cui Y; Liu M; Ma X; Liu Y; Cui W; Sun L; Teng L; Wang L; Lin A; Liu W; Zhuo W; Zhou T
    Exp Mol Med; 2023 Feb; 55(2):457-469. PubMed ID: 36797541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallmarks of Cancer Affected by the MIF Cytokine Family.
    Mora Barthelmess R; Stijlemans B; Van Ginderachter JA
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.
    Bhatia A; Burtness B
    Drugs; 2023 Feb; 83(3):217-248. PubMed ID: 36645621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD74 as a regulator of transcription in normal B cells.
    David K; Friedlander G; Pellegrino B; Radomir L; Lewinsky H; Leng L; Bucala R; Becker-Herman S; Shachar I
    Cell Rep; 2022 Nov; 41(5):111572. PubMed ID: 36323260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
    Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
    Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.
    Wang L; Li S; Luo H; Lu Q; Yu S
    J Exp Clin Cancer Res; 2022 Oct; 41(1):303. PubMed ID: 36242053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MIF1/MIF2/CD74 interactions in bladder cancer.
    Woolbright BL; Rajendran G; Abbott E; Martin A; Amalraj S; Dennis K; Li X; Warrick J; Taylor JA
    J Pathol; 2023 Jan; 259(1):46-55. PubMed ID: 36214539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.
    Thiele M; Donnelly SC; Mitchell RA
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180072
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.